biostudies-literatureUnknown390(10106)Coleman RLStand Up To CancerErgomedAmgenCancer Research UKUniversity College LondonUS Department of Defense Ovarian Cancer Research ProgramOncoMedOvarian Cancer Research FundMerckAjinomotoRegeneronRocheImmunogenJanssenClovis OncologyMillenniumAstraZenecaExperimental Cancer Medicine Centres at GlasgowV Foundation Translational AwardEMD SeronoAbbVieVentiRxOvarian Cancer Research Fund AllianceStand Up to Cancer is a programme of the Entertainment Industry FoundationGenentechMedical Research CouncilNational Ovarian Cancer Coalition Dream Team Translational Research GrantNCI NIH HHSMemorial Sloan Kettering Cancer CenterArray BiopharmaGamaMabs and MerusAmerican Association for Cancer ResearchEsperanceLancet (London, England)1949-1961https://www.ebi.ac.uk/biostudies/studies/S-EPMC5901715biostudies-literatureRucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.PMC5901715P30 CA016058P30 CA016672OC120506G0501974P30 CA008748SU2C-AACR-DT16–15151568515973G0601891Slomovitz BMShapira-Frommer RHolloway RWAghajanian CKovel SZamagni CChen LMGiordano HGoh JCHarding TCGarcia-Donas JLedermann JAScambia GPolcher MIsaacson JGladieff LGoble SSun JMedioni JTamberi SPignata SBanerjee SNNeunhoffer TLorusso DSafra TTredan OPalacio IWelch SLeary ASabbatini RFHarnett PProvencher DGabra HGKonecny GEBuck MARIEL3 investigatorsEl-Balat ABirrer MJVanderkwaak TColombo NElit LBuss MKFloquet ADirix LAmit AMa LWeberpals JILin KKKrabisch PColeman RLMaloney LFriedlander MLHerraez ACLortholary AJoly FLotz JGhatage PGrace COaknin AO'Malley DMJackson DChambers SKHanle CGancedo MAMorgan MAVulfovich MKichenadasse GPowell MArmstrong DKRomero ISwisher EMOza AMScott CLLeviov MDrew YDenys HParkinson CDean AFong PCVergote IClamp AGuerra EMPlante MSanchez AO'Donnell AMorris RTMcNeish IAWimberger PCameron TStemmer SMutch DGYou BBologna ARaponi MfalseRucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.2017-01-01T00:00:00Z2017 Oct2026-04-30T19:16:57.585Z2025-04-06T08:27:21.095ZS-EPMC59017152891636710.1016/S0140-6736(17)32440-610.1016/s0140-6736(17)32440-6